On this episode of Sequenced, we talk to Lindsay Avner, Founder and CEO of Bright Pink. Lindsay underwent genetic testing at age 22. The test revealed she carried a mutation on the BRCA1 gene. At 23, she became the youngest woman in the U.S. to undergo a risk-reducing double mastectomy. Lindsay shares her commitment to live proactively, why she founded Bright Pink, and how women can be advocates for their own health.
Bright Pink is a national non-profit organization that focuses on saving women’s lives from breast and ovarian cancer by empowering them to live proactively at a young age. Bright Pink offers interactive digital tools to help women assess their risk for breast and ovarian cancer (assessyourrisk.org) and address their questions around genetic testing (exploreyourgenetics.org).